Categories
Latest News
- Toft Group Executive Search Successfully Places Jane Wasman on Board of Directors for Rigel Pharmaceuticals in South San Francisco, CA04/04/2019 - 11:06 AM
- Toft Group Executive Search Successfully Places Magda Marquet, Ph.D. on Board of Directors for Pfenex Inc. in San Diego, CA04/04/2019 - 10:51 AM
- Toft Group Executive Search Places Andrea Chow, PhD as Senior Vice President of Engineering at Two Pore Guys, Inc. in Santa Cruz, CA04/04/2019 - 10:49 AM
Toft Group Executive Search Successfully Places Jane Wasman on Board of Directors for Rigel Pharmaceuticals in South San Francisco, CA
/in Press Releases /by ToftgroupToft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Jane Wasman on the Board of Directors for Rigel Pharmaceuticals in South San Francisco, CA. Ms. Wasman is a strategic leader with over 20 years of experience in the biopharma industry working with both large multinational corporations and privately held start-ups. Her expertise includes strategic development, corporate governance, litigation, commercialization, compliance and government affairs, and operational implementation.
Ms. Wasman currently serves as President, International and General Counsel at Acorda Therapeutics. Prior to joining Acorda, Ms. Wasman held various leadership positions at Schering-Plough Corporation, including Staff Vice President and Associate General Counsel. Previously, she was an attorney at two global law firms and Associate Counsel for the U.S. Senate Veterans’ Affairs Committee. Ms. Wasman is Chair of the Board of Sellas Life Sciences and serves on the board of the non-profit NewYorkBIO.
Ms. Wasman graduated magna cum laude from Princeton University, and earned her J.D. from Harvard Law School.
About Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Rigel’s pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company’s first FDA approved product is TAVALISSE® (fostamatinib disodium hexahydrate), the only oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. Rigel’s clinical programs include an upcoming Phase 3 study of fostamatinib in autoimmune hemolytic anemia and an ongoing Phase 1 study of R835, a proprietary molecule from its interleukin receptor associated kinase (IRAK) program. In addition, Rigel has product candidates in clinical development with partners BerGenBio ASA, Daiichi Sankyo, Aclaris Therapeutics and AstraZeneca.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
Toft Group Executive Search Successfully Places Magda Marquet, Ph.D. on Board of Directors for Pfenex Inc. in San Diego, CA
/in Press Releases /by ToftgroupToft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Magda Marquet, Ph.D. on the Board of Directors for Pfenex Inc. in San Diego, CA. Dr. Marquet was also appointed to serve as a member of the corporate governance and nominating committee.
Dr. Marquet co-founded Althea Technologies and led the company as co-CEO for ten years. Currently, Dr. Marquet is the co-Founder and co-CEO of ALMA Life Sciences, an early stage investment firm focusing on the creation and growth of innovative healthcare companies. Dr. Marquet is also the co-founder of AltheaDx, a commercial stage precision medicine company with the world’s leading pharmacogenomics test for anxiety and depression.
Dr. Marquet serves as a board member of Arcturus Therapeutics. She is an advisor to Mesa Verde Venture Partners and City National Bank. Dr. Marquet serves on several non-profit boards, including BIOCOM, CONNECT, EDC and Moores Cancer Center at UC San Diego. She holds a Ph.D. in Biochemical Engineering from INSA/University of Toulouse, France.
About Pfenex, Inc.
Pfenex, Inc. is a clinical-stage development and licensing biotechnology company focused on leveraging the Pfēnex Expression Technology® to develop and improve protein therapies for unmet patient needs. Using the patented Pfēnex Expression Technology platform, they have created an advanced pipeline of therapeutic equivalents, vaccines, biologics and biosimilars.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
Toft Group Executive Search Places Andrea Chow, PhD as Senior Vice President of Engineering at Two Pore Guys, Inc. in Santa Cruz, CA
/in Press Releases /by ToftgroupToft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has placed Andrea Chow, PhD as Senior Vice President of Engineering at Two Pore Guys, Inc. in Santa Cruz, CA.
Dr. Chow has over 25 years of broad R&D experience in the life science and aerospace industries, developing leading edge technologies in microfluidics, microfabrication, biomolecular transport, detection instrumentation and advanced material processing. She formerly served as the VP of Measurements and Engineering at BioElectron. Previously, Dr. Chow was with Promega as their Sr. Director of Integrated Engineering. Prior to Promega, she was the Co-Founder, Chief Financial Officer & Chief Operating Officer of Caerus Molecular Diagnostics. She co-founded this startup focused on low-cost and high accuracy DNA sequencing technologies. She has also served as an Engineering Consultant to various life science and medical device companies in relation to product and business development.
Dr. Chow was named among “100 Chemical Engineers of the Modern Era” by the American Institute of Chemical Engineers. Dr Chow has a PhD in Chemical Engineering from Stanford University.
About Two Pore Guys, Inc.
Two Pore Guys, Inc. develops single molecule biosensors for diagnostic uses. The company focuses on developing digital, hand-held, and single molecule biosensors that detect viruses, bacteria, antibodies, and other pathogens; and track disease progression.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.